Jian Can-Hui, Luo Shuai, Wang Jin-Jing
Pathology Department, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Front Oncol. 2024 Dec 11;14:1509132. doi: 10.3389/fonc.2024.1509132. eCollection 2024.
Primary pulmonary hyalinizing clear cell carcinoma (HCCC) is a rare type of primary salivary gland-type tumor of the lung. HCCC is characterized by unique pathological features, including nests, cords, or trabeculae of clear or eosinophilic tumor cells infiltrating a mucinous or hyalinized stroma. Additional analyses of this carcinoma have revealed positive epithelial markers via immunophenotyping and gene translocation through genetic testing. However, the morphology of HCCC has been found to change during bronchoscopic biopsy, suggesting certain challenges for its clinical diagnosis and treatment.
A 47-year-old female patient presented with a 2-month history of cough, sputum production, and dyspnea. A chest CT scan found a nodular soft tissue density shadow in the lower segment of the trachea. Subsequently, the patient underwent tumor resection via combined flexible and rigid bronchoscopy. Postoperative pathological examination, including immunohistochemistry and molecular testing, confirmed an gene translocation. The final pathological diagnosis was primary pulmonary HCCC. A follow-up at 6 months post-surgery showed mediastinal lymph node metastasis.
Primary pulmonary HCCC is an extremely rare, low-grade malignant epithelial tumor of the lung, which has a notably difficult clinical diagnosis and treatment due to the absence of a standard treatment protocol. This case report presents a patient with primary pulmonary HCCC confirmed by molecular testing, aiming to raise awareness about this tumor among physicians and provide valuable clinical references.
原发性肺透明细胞硬化性癌(HCCC)是一种罕见的原发性肺唾液腺型肿瘤。HCCC具有独特的病理特征,包括透明或嗜酸性肿瘤细胞巢、索状或小梁状结构浸润黏液样或透明变性的间质。对该肿瘤的进一步分析显示,通过免疫表型分析上皮标志物呈阳性,通过基因检测发现基因易位。然而,已发现HCCC的形态在支气管镜活检过程中会发生变化,这给其临床诊断和治疗带来了一定挑战。
一名47岁女性患者,有2个月的咳嗽、咳痰和呼吸困难病史。胸部CT扫描发现气管下段有一个结节状软组织密度影。随后,患者通过软性和硬性支气管镜联合进行了肿瘤切除。术后病理检查,包括免疫组织化学和分子检测,证实存在基因易位。最终病理诊断为原发性肺HCCC。术后6个月的随访显示有纵隔淋巴结转移。
原发性肺HCCC是一种极其罕见的低度恶性肺上皮肿瘤,由于缺乏标准治疗方案,其临床诊断和治疗极具难度。本病例报告介绍了一名经分子检测确诊为原发性肺HCCC的患者,旨在提高医生对该肿瘤的认识,并提供有价值的临床参考。